Boc-N-methyl-O-benzyl-L-threonine (CAS 64263-80-5): A Key Amino Acid Derivative for Pharmaceutical Innovation

Discover the essential role of Boc-N-methyl-O-benzyl-L-threonine in advancing pharmaceutical research and drug development. As a leading supplier in China, we offer high-purity compounds crucial for complex peptide synthesis and innovative therapeutic solutions. Get your quote today!

Get a Quote & Sample

Key Advantages for Your Pharmaceutical R&D

Enhanced Synthesis Precision

The carefully designed structure of Boc-N-methyl-O-benzyl-L-threonine, with its Boc and benzyl protecting groups, allows for selective reactions, making it a preferred choice for complex peptide synthesis and ensuring higher yields for R&D scientists.

Accelerated Drug Discovery

As a critical building block, this amino acid derivative significantly contributes to the development of new drug candidates and the improvement of API stability and bioavailability, supporting faster innovation cycles.

Guaranteed Quality and Consistency

We are committed to providing consistently high-quality Boc-N-methyl-O-benzyl-L-threonine. Strict quality control ensures that our product meets the ≥98.0% assay requirement, a crucial factor for pharmaceutical manufacturers seeking reliable materials.

Core Applications in Pharmaceutical Synthesis

Peptide Synthesis

An indispensable component for constructing specific peptide sequences, vital for therapeutic peptides targeting various diseases. Our compound is a key ingredient for those looking to buy high purity peptide synthesis reagents.

Pharmaceutical Intermediates

Serves as a crucial intermediate in the synthesis of Active Pharmaceutical Ingredients (APIs), enabling the creation of complex molecules with therapeutic value. Explore pricing for pharmaceutical intermediate suppliers.

Drug Candidate Development

A versatile building block that aids in enhancing the stability and bioavailability of potential drug candidates, accelerating the drug discovery pipeline for research institutions and pharmaceutical companies.

Bioconjugation and Targeted Delivery

Facilitates the creation of advanced drug delivery systems, offering precise therapeutic actions and improved patient outcomes. Essential for companies researching bioconjugation techniques.